Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Rates of survival after out-of-hospital cardiac arrest (OHCA) have not fully bounced back since the COVID-19 pandemic, ...

Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Johnson & Johnson received Food and Drug Administration approval for its Varipulse pulsed field ablation (PFA) system, ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...

In a series of significant industry advancements, the U.S. FDA has given its nod to Johnson & Johnson's Varipulse device ...